Global Gastrointestinal Stromal Tumor (GIST) Drug Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Gastrointestinal Stromal Tumor (GIST) Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastrointestinal Stromal Tumor (GIST) Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastrointestinal Stromal Tumor (GIST) Drug market in any manner.
Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
Market Segmentation (by Type)
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
Market Segmentation (by Application)
Clinic
Hospital
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Stromal Tumor (GIST) Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Gastrointestinal Stromal Tumor (GIST) Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastrointestinal Stromal Tumor (GIST) Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastrointestinal Stromal Tumor (GIST) Drug market in any manner.
Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Ariad Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc.
Array BioPharma Inc.
Astex Pharmaceuticals, Inc.
Blueprint Medicines Corporation
Boston Biomedical, Inc.
Calithera Biosciences, Inc.
Chipscreen Biosciences Ltd
Deciphera Pharmaceuticals, LLC
F. Hoffmann-La Roche Ltd.
Horizon Pharma Plc
Immunicum AB
Jiangsu Hengrui Medicine Co., Ltd.
Kolltan Pharmaceuticals, Inc.
Natco Pharma Limited
Nerviano Medical Sciences S.r.l.
Novartis AG
Omeros Corporation
Market Segmentation (by Type)
Amcasertib
Anagrelide hydrochloride CR
APG-1351
Binimetinib
Others
Market Segmentation (by Application)
Clinic
Hospital
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gastrointestinal Stromal Tumor (GIST) Drug Market
- Overview of the regional outlook of the Gastrointestinal Stromal Tumor (GIST) Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal Stromal Tumor (GIST) Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gastrointestinal Stromal Tumor (GIST) Drug
1.2 Key Market Segments
1.2.1 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type
1.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturers (2019-2024)
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Sales Sites, Area Served, Product Type
3.6 Gastrointestinal Stromal Tumor (GIST) Drug Market Competitive Situation and Trends
3.6.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gastrointestinal Stromal Tumor (GIST) Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG INDUSTRY CHAIN ANALYSIS
4.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2019-2024)
6.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Market Share by Type (2019-2024)
6.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2019-2024)
7 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Sales by Application (2019-2024)
7.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate by Application (2019-2024)
8 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SEGMENTATION BY REGION
8.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region
8.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region
8.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Ariad Pharmaceuticals, Inc.
9.1.1 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.1.2 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.1.4 Ariad Pharmaceuticals, Inc. Business Overview
9.1.5 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug SWOT Analysis
9.1.6 Ariad Pharmaceuticals, Inc. Recent Developments
9.2 Arog Pharmaceuticals, Inc.
9.2.1 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.2.2 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.2.4 Arog Pharmaceuticals, Inc. Business Overview
9.2.5 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug SWOT Analysis
9.2.6 Arog Pharmaceuticals, Inc. Recent Developments
9.3 Array BioPharma Inc.
9.3.1 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.3.2 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug SWOT Analysis
9.3.5 Array BioPharma Inc. Business Overview
9.3.6 Array BioPharma Inc. Recent Developments
9.4 Astex Pharmaceuticals, Inc.
9.4.1 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.4.2 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.4.4 Astex Pharmaceuticals, Inc. Business Overview
9.4.5 Astex Pharmaceuticals, Inc. Recent Developments
9.5 Blueprint Medicines Corporation
9.5.1 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.5.2 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.5.4 Blueprint Medicines Corporation Business Overview
9.5.5 Blueprint Medicines Corporation Recent Developments
9.6 Boston Biomedical, Inc.
9.6.1 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.6.2 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.6.4 Boston Biomedical, Inc. Business Overview
9.6.5 Boston Biomedical, Inc. Recent Developments
9.7 Calithera Biosciences, Inc.
9.7.1 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.7.2 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.7.4 Calithera Biosciences, Inc. Business Overview
9.7.5 Calithera Biosciences, Inc. Recent Developments
9.8 Chipscreen Biosciences Ltd
9.8.1 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.8.2 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.8.4 Chipscreen Biosciences Ltd Business Overview
9.8.5 Chipscreen Biosciences Ltd Recent Developments
9.9 Deciphera Pharmaceuticals, LLC
9.9.1 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.9.2 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.9.4 Deciphera Pharmaceuticals, LLC Business Overview
9.9.5 Deciphera Pharmaceuticals, LLC Recent Developments
9.10 F. Hoffmann-La Roche Ltd.
9.10.1 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.10.2 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.10.4 F. Hoffmann-La Roche Ltd. Business Overview
9.10.5 F. Hoffmann-La Roche Ltd. Recent Developments
9.11 Horizon Pharma Plc
9.11.1 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.11.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.11.4 Horizon Pharma Plc Business Overview
9.11.5 Horizon Pharma Plc Recent Developments
9.12 Immunicum AB
9.12.1 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.12.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.12.4 Immunicum AB Business Overview
9.12.5 Immunicum AB Recent Developments
9.13 Jiangsu Hengrui Medicine Co., Ltd.
9.13.1 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.13.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.13.4 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
9.13.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
9.14 Kolltan Pharmaceuticals, Inc.
9.14.1 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.14.2 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.14.4 Kolltan Pharmaceuticals, Inc. Business Overview
9.14.5 Kolltan Pharmaceuticals, Inc. Recent Developments
9.15 Natco Pharma Limited
9.15.1 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.15.2 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.15.4 Natco Pharma Limited Business Overview
9.15.5 Natco Pharma Limited Recent Developments
9.16 Nerviano Medical Sciences S.r.l.
9.16.1 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.16.2 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.16.4 Nerviano Medical Sciences S.r.l. Business Overview
9.16.5 Nerviano Medical Sciences S.r.l. Recent Developments
9.17 Novartis AG
9.17.1 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.17.2 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.17.4 Novartis AG Business Overview
9.17.5 Novartis AG Recent Developments
9.18 Omeros Corporation
9.18.1 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.18.2 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.18.4 Omeros Corporation Business Overview
9.18.5 Omeros Corporation Recent Developments
10 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET FORECAST BY REGION
10.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast
10.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country
10.2.3 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Region
10.2.4 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2025-2030)
11.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2025-2030)
11.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast by Application (2025-2030)
11.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gastrointestinal Stromal Tumor (GIST) Drug
1.2 Key Market Segments
1.2.1 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type
1.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturers (2019-2024)
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Sales Sites, Area Served, Product Type
3.6 Gastrointestinal Stromal Tumor (GIST) Drug Market Competitive Situation and Trends
3.6.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gastrointestinal Stromal Tumor (GIST) Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG INDUSTRY CHAIN ANALYSIS
4.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2019-2024)
6.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Market Share by Type (2019-2024)
6.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2019-2024)
7 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Sales by Application (2019-2024)
7.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate by Application (2019-2024)
8 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET SEGMENTATION BY REGION
8.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region
8.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region
8.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Ariad Pharmaceuticals, Inc.
9.1.1 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.1.2 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.1.4 Ariad Pharmaceuticals, Inc. Business Overview
9.1.5 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug SWOT Analysis
9.1.6 Ariad Pharmaceuticals, Inc. Recent Developments
9.2 Arog Pharmaceuticals, Inc.
9.2.1 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.2.2 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.2.4 Arog Pharmaceuticals, Inc. Business Overview
9.2.5 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug SWOT Analysis
9.2.6 Arog Pharmaceuticals, Inc. Recent Developments
9.3 Array BioPharma Inc.
9.3.1 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.3.2 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug SWOT Analysis
9.3.5 Array BioPharma Inc. Business Overview
9.3.6 Array BioPharma Inc. Recent Developments
9.4 Astex Pharmaceuticals, Inc.
9.4.1 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.4.2 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.4.4 Astex Pharmaceuticals, Inc. Business Overview
9.4.5 Astex Pharmaceuticals, Inc. Recent Developments
9.5 Blueprint Medicines Corporation
9.5.1 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.5.2 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.5.4 Blueprint Medicines Corporation Business Overview
9.5.5 Blueprint Medicines Corporation Recent Developments
9.6 Boston Biomedical, Inc.
9.6.1 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.6.2 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.6.4 Boston Biomedical, Inc. Business Overview
9.6.5 Boston Biomedical, Inc. Recent Developments
9.7 Calithera Biosciences, Inc.
9.7.1 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.7.2 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.7.4 Calithera Biosciences, Inc. Business Overview
9.7.5 Calithera Biosciences, Inc. Recent Developments
9.8 Chipscreen Biosciences Ltd
9.8.1 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.8.2 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.8.4 Chipscreen Biosciences Ltd Business Overview
9.8.5 Chipscreen Biosciences Ltd Recent Developments
9.9 Deciphera Pharmaceuticals, LLC
9.9.1 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.9.2 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.9.4 Deciphera Pharmaceuticals, LLC Business Overview
9.9.5 Deciphera Pharmaceuticals, LLC Recent Developments
9.10 F. Hoffmann-La Roche Ltd.
9.10.1 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.10.2 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.10.4 F. Hoffmann-La Roche Ltd. Business Overview
9.10.5 F. Hoffmann-La Roche Ltd. Recent Developments
9.11 Horizon Pharma Plc
9.11.1 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.11.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.11.4 Horizon Pharma Plc Business Overview
9.11.5 Horizon Pharma Plc Recent Developments
9.12 Immunicum AB
9.12.1 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.12.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.12.4 Immunicum AB Business Overview
9.12.5 Immunicum AB Recent Developments
9.13 Jiangsu Hengrui Medicine Co., Ltd.
9.13.1 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.13.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.13.4 Jiangsu Hengrui Medicine Co., Ltd. Business Overview
9.13.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
9.14 Kolltan Pharmaceuticals, Inc.
9.14.1 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.14.2 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.14.4 Kolltan Pharmaceuticals, Inc. Business Overview
9.14.5 Kolltan Pharmaceuticals, Inc. Recent Developments
9.15 Natco Pharma Limited
9.15.1 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.15.2 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.15.4 Natco Pharma Limited Business Overview
9.15.5 Natco Pharma Limited Recent Developments
9.16 Nerviano Medical Sciences S.r.l.
9.16.1 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.16.2 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.16.4 Nerviano Medical Sciences S.r.l. Business Overview
9.16.5 Nerviano Medical Sciences S.r.l. Recent Developments
9.17 Novartis AG
9.17.1 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.17.2 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.17.4 Novartis AG Business Overview
9.17.5 Novartis AG Recent Developments
9.18 Omeros Corporation
9.18.1 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
9.18.2 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
9.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Market Performance
9.18.4 Omeros Corporation Business Overview
9.18.5 Omeros Corporation Recent Developments
10 GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG MARKET FORECAST BY REGION
10.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast
10.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country
10.2.3 Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Region
10.2.4 South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gastrointestinal Stromal Tumor (GIST) Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2025-2030)
11.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2025-2030)
11.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast by Application (2025-2030)
11.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastrointestinal Stromal Tumor (GIST) Drug Market Size Comparison by Region (M USD)
Table 5. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor (GIST) Drug as of 2022)
Table 10. Global Market Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Sales Sites and Area Served
Table 12. Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Type
Table 13. Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gastrointestinal Stromal Tumor (GIST) Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges
Table 22. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (Kilotons)
Table 23. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (M USD)
Table 24. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2019-2024)
Table 26. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Share by Type (2019-2024)
Table 28. Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons) by Application
Table 30. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
Table 31. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2019-2024)
Table 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2019-2024)
Table 35. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2019-2024)
Table 38. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 44. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 45. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Ariad Pharmaceuticals, Inc. Business Overview
Table 47. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug SWOT Analysis
Table 48. Ariad Pharmaceuticals, Inc. Recent Developments
Table 49. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 50. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 51. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Arog Pharmaceuticals, Inc. Business Overview
Table 53. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug SWOT Analysis
Table 54. Arog Pharmaceuticals, Inc. Recent Developments
Table 55. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 56. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 57. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug SWOT Analysis
Table 59. Array BioPharma Inc. Business Overview
Table 60. Array BioPharma Inc. Recent Developments
Table 61. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 62. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 63. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Astex Pharmaceuticals, Inc. Business Overview
Table 65. Astex Pharmaceuticals, Inc. Recent Developments
Table 66. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 67. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 68. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Blueprint Medicines Corporation Business Overview
Table 70. Blueprint Medicines Corporation Recent Developments
Table 71. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 72. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 73. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Boston Biomedical, Inc. Business Overview
Table 75. Boston Biomedical, Inc. Recent Developments
Table 76. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 77. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 78. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Calithera Biosciences, Inc. Business Overview
Table 80. Calithera Biosciences, Inc. Recent Developments
Table 81. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 82. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 83. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Chipscreen Biosciences Ltd Business Overview
Table 85. Chipscreen Biosciences Ltd Recent Developments
Table 86. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 87. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 88. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Deciphera Pharmaceuticals, LLC Business Overview
Table 90. Deciphera Pharmaceuticals, LLC Recent Developments
Table 91. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 92. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 93. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. F. Hoffmann-La Roche Ltd. Business Overview
Table 95. F. Hoffmann-La Roche Ltd. Recent Developments
Table 96. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 97. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 98. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Horizon Pharma Plc Business Overview
Table 100. Horizon Pharma Plc Recent Developments
Table 101. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 102. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 103. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Immunicum AB Business Overview
Table 105. Immunicum AB Recent Developments
Table 106. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 107. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 108. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Jiangsu Hengrui Medicine Co., Ltd. Business Overview
Table 110. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
Table 111. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 112. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 113. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Kolltan Pharmaceuticals, Inc. Business Overview
Table 115. Kolltan Pharmaceuticals, Inc. Recent Developments
Table 116. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 117. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 118. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Natco Pharma Limited Business Overview
Table 120. Natco Pharma Limited Recent Developments
Table 121. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 122. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 123. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Nerviano Medical Sciences S.r.l. Business Overview
Table 125. Nerviano Medical Sciences S.r.l. Recent Developments
Table 126. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 127. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 128. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Novartis AG Business Overview
Table 130. Novartis AG Recent Developments
Table 131. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 132. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 133. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Omeros Corporation Business Overview
Table 135. Omeros Corporation Recent Developments
Table 136. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Gastrointestinal Stromal Tumor (GIST) Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastrointestinal Stromal Tumor (GIST) Drug Market Size Comparison by Region (M USD)
Table 5. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor (GIST) Drug as of 2022)
Table 10. Global Market Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Sales Sites and Area Served
Table 12. Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Type
Table 13. Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Gastrointestinal Stromal Tumor (GIST) Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges
Table 22. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (Kilotons)
Table 23. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type (M USD)
Table 24. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2019-2024)
Table 26. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Share by Type (2019-2024)
Table 28. Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons) by Application
Table 30. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
Table 31. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2019-2024)
Table 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2019-2024)
Table 35. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2019-2024)
Table 38. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 44. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 45. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Ariad Pharmaceuticals, Inc. Business Overview
Table 47. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug SWOT Analysis
Table 48. Ariad Pharmaceuticals, Inc. Recent Developments
Table 49. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 50. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 51. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Arog Pharmaceuticals, Inc. Business Overview
Table 53. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug SWOT Analysis
Table 54. Arog Pharmaceuticals, Inc. Recent Developments
Table 55. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 56. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 57. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug SWOT Analysis
Table 59. Array BioPharma Inc. Business Overview
Table 60. Array BioPharma Inc. Recent Developments
Table 61. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 62. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 63. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Astex Pharmaceuticals, Inc. Business Overview
Table 65. Astex Pharmaceuticals, Inc. Recent Developments
Table 66. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 67. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 68. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Blueprint Medicines Corporation Business Overview
Table 70. Blueprint Medicines Corporation Recent Developments
Table 71. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 72. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 73. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Boston Biomedical, Inc. Business Overview
Table 75. Boston Biomedical, Inc. Recent Developments
Table 76. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 77. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 78. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Calithera Biosciences, Inc. Business Overview
Table 80. Calithera Biosciences, Inc. Recent Developments
Table 81. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 82. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 83. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Chipscreen Biosciences Ltd Business Overview
Table 85. Chipscreen Biosciences Ltd Recent Developments
Table 86. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 87. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 88. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Deciphera Pharmaceuticals, LLC Business Overview
Table 90. Deciphera Pharmaceuticals, LLC Recent Developments
Table 91. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 92. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 93. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. F. Hoffmann-La Roche Ltd. Business Overview
Table 95. F. Hoffmann-La Roche Ltd. Recent Developments
Table 96. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 97. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 98. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Horizon Pharma Plc Business Overview
Table 100. Horizon Pharma Plc Recent Developments
Table 101. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 102. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 103. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Immunicum AB Business Overview
Table 105. Immunicum AB Recent Developments
Table 106. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 107. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 108. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Jiangsu Hengrui Medicine Co., Ltd. Business Overview
Table 110. Jiangsu Hengrui Medicine Co., Ltd. Recent Developments
Table 111. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 112. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 113. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Kolltan Pharmaceuticals, Inc. Business Overview
Table 115. Kolltan Pharmaceuticals, Inc. Recent Developments
Table 116. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 117. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 118. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Natco Pharma Limited Business Overview
Table 120. Natco Pharma Limited Recent Developments
Table 121. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 122. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 123. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Nerviano Medical Sciences S.r.l. Business Overview
Table 125. Nerviano Medical Sciences S.r.l. Recent Developments
Table 126. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 127. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 128. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Novartis AG Business Overview
Table 130. Novartis AG Recent Developments
Table 131. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Basic Information
Table 132. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Overview
Table 133. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Omeros Corporation Business Overview
Table 135. Omeros Corporation Recent Developments
Table 136. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 137. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 139. North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 141. Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 143. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 145. South America Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 149. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Gastrointestinal Stromal Tumor (GIST) Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 151. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 152. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (M USD), 2019-2030
Figure 5. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (M USD) (2019-2030)
Figure 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country (M USD)
Figure 11. Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Manufacturers in 2023
Figure 12. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers in 2023
Figure 13. Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal Stromal Tumor (GIST) Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type
Figure 18. Sales Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2019-2024)
Figure 19. Sales Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type in 2023
Figure 20. Market Size Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application
Figure 24. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application in 2023
Figure 26. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2019-2024)
Figure 27. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application in 2023
Figure 28. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country in 2023
Figure 32. U.S. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country in 2023
Figure 37. Germany Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region in 2023
Figure 44. China Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country in 2023
Figure 51. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (M USD), 2019-2030
Figure 5. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (M USD) (2019-2030)
Figure 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country (M USD)
Figure 11. Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Manufacturers in 2023
Figure 12. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers in 2023
Figure 13. Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal Stromal Tumor (GIST) Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type
Figure 18. Sales Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2019-2024)
Figure 19. Sales Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type in 2023
Figure 20. Market Size Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Gastrointestinal Stromal Tumor (GIST) Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application
Figure 24. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application in 2023
Figure 26. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2019-2024)
Figure 27. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application in 2023
Figure 28. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country in 2023
Figure 32. U.S. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Gastrointestinal Stromal Tumor (GIST) Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country in 2023
Figure 37. Germany Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region in 2023
Figure 44. China Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country in 2023
Figure 51. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share Forecast by Application (2025-2030)
